Evidence map›Paper›PMID 34676489›Full record

ArticlePharmaceutical research2021

A robust method for the assessment of average bioequivalence in the presence of outliers and skewness.

Divan Aristo Burger, Robert Schall, Sean van der Merwe

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Divan Aristo BurgerDepartment of Statistics, University of Pretoria, Pretoria, South Africa. divanaburger@gmail.com.ORCID http://orcid.org/0000-0001-8096-6371
Robert SchallDepartment of Mathematical Statistics and Actuarial Science, University of the Free State, Bloemfontein, South Africa.
Sean van der MerweDepartment of Mathematical Statistics and Actuarial Science, University of the Free State, Bloemfontein, South Africa.

Funding

research development programme at the university of pretoria 219/2018south africa dst-nrf-samrc sarchi research chair in biostatistics 114613
6 · The paper itself

Abstract

purposeIn this paper, we propose a robust Bayesian method for the assessment of average bioequivalence based on data from conventional crossover studies. We evaluate and motivate empirically the need for robust methods in bioequivalence studies by comparing the results of robust and conventional statistical methods in a large data pool of bioequivalence studies.

methodsRobustness of the statistical methodology is achieved by replacing the normal distributions for residuals in the linear mixed model with skew-t distributions. In this way, the statistical model can accommodate skew and heavy-tailed data, particularly outliers, yielding robust statistical inference without the need for excluding outliers from the analysis. We performed a simulation study to investigate and compare the performance of the robust and conventional models.

resultsOur study shows that in some trials, the distribution of residuals is skew and heavy-tailed. In the presence of outliers, the 90% confidence intervals for the ratio of geometric means tend to be narrower for the robust methods than for the conventional method. Our simulation study shows that the robust method has suitable frequentist properties and yields more precise confidence intervals and higher statistical power than the conventional maximum likelihood method when outliers are present in the data.

conclusionsAs a sensitivity analysis, we recommend the fit of robust models for handling outliers that are occasionally encountered in crossover design bioequivalence data.

Indexed as

Bayes TheoremComputer SimulationHumansLinear ModelsModels, BiologicalResearch DesignStatistics as TopicTherapeutic Equivalencyaverage bioequivalenceBayesianoutliersrobustskew-t

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.